Skip to main content

ADVERTISEMENT

Podcasts

Jean Liew
Podcast
07/21/2022
Dr Liew, from Boston University School of Medicine, discusses her recent research into whether treating patients with ankylosing spondylitis with anti-tumor necrosis factor inhibitors may contribute to hypertension.
Dr Liew, from Boston University School of Medicine, discusses her recent research into whether treating patients with ankylosing spondylitis with anti-tumor necrosis factor inhibitors may contribute to hypertension.
Dr Liew, from Boston University...
07/21/2022
Rheumatology & Arthritis
The Neurologist Is In podcast.
Podcasts
07/18/2022
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Mark J. Milstein, MD, FAAN, to discuss how he discovered his interest in medical education and future trends in neurology training.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Mark J. Milstein, MD, FAAN, to discuss how he discovered his interest in medical education and future trends in neurology training.
In this episode, Rachel Marie E....
07/18/2022
Neurology
Kelly Gavighan
Podcast
07/15/2022
Kelly Gavighan, MPH, director of data management and analytics for the Global Healthy Living Foundation, discusses the research she presented at EULAR 2022 on changes in patient-reported outcome scores among patients with rheumatic diseases...
Kelly Gavighan, MPH, director of data management and analytics for the Global Healthy Living Foundation, discusses the research she presented at EULAR 2022 on changes in patient-reported outcome scores among patients with rheumatic diseases...
Kelly Gavighan, MPH, director of...
07/15/2022
Rheumatology & Arthritis
Gunn and McClure
Podcast
07/15/2022
In our first offering from the Society of Interventional Oncology (SIO) Corner, guest host A.J. Gunn, MD, Vice Chair of the SIO's Publications Committee, speaks with Weill Cornell’s Timothy McClure, MD, about his abstract on the medium- and...
In our first offering from the Society of Interventional Oncology (SIO) Corner, guest host A.J. Gunn, MD, Vice Chair of the SIO's Publications Committee, speaks with Weill Cornell’s Timothy McClure, MD, about his abstract on the medium- and...
In our first offering from the...
07/15/2022
IO Learning
Arndt Vogel, MD, Hannover Medical School
Podcasts
07/14/2022
Arndt Vogel, MD, shares results from the phase 2, FIGHT-202 trial which evaluated pemigatinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma.
Arndt Vogel, MD, shares results from the phase 2, FIGHT-202 trial which evaluated pemigatinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma.
Arndt Vogel, MD, shares results...
07/14/2022
Oncology
Rena Yadlapati
Podcast
07/13/2022
In this podcast, Dr Rita Knotts discusses Chicago Classification 4.0 for esophageal motility disorders on high-resolution manometry with Dr Rena Yadlapati, who was involved in developing the updated guidelines.
In this podcast, Dr Rita Knotts discusses Chicago Classification 4.0 for esophageal motility disorders on high-resolution manometry with Dr Rena Yadlapati, who was involved in developing the updated guidelines.
In this podcast, Dr Rita Knotts...
07/13/2022
Gastroenterology
Headshot of Angie Franks, ABOUT, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
07/12/2022
Angie Franks, CEO, ABOUT, discusses challenges health systems face when transferring patients between facilities, and shares how optimizing processes can improve revenue and clinical outcomes.
Angie Franks, CEO, ABOUT, discusses challenges health systems face when transferring patients between facilities, and shares how optimizing processes can improve revenue and clinical outcomes.
Angie Franks, CEO, ABOUT,...
07/12/2022
Integrated Healthcare Executive
IBD Drive time logo
Podcast
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
Vikas Majithia, MD, on the Difficulties of Diagnosing Psoriatic Arthritis
Podcasts
07/12/2022
In this podcast, Vikas Majithia, MD, from the Mayo Clinic in Jacksonville, Florida, discusses some of the difficulties rheumatologists encounter when diagnosing psoriatic arthritis, and key indicators of the disease. 
In this podcast, Vikas Majithia, MD, from the Mayo Clinic in Jacksonville, Florida, discusses some of the difficulties rheumatologists encounter when diagnosing psoriatic arthritis, and key indicators of the disease. 
In this podcast, Vikas Majithia,...
07/12/2022
Rheumatology & Arthritis